📰 One Nucleus News
One Nucleus News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from One Nucleus. Real-time updates on events, politics, business and more.
April 11, 2024
While the UK is not short of life science start-up companies there is a disconnect when it comes to scaling up, with many choosing to relocate to other markets with perceived better opportunities, writes Sarah Brereton, Director at Limewash Media.
December 15, 2023
My Green Lab Welcomes AstraZeneca’s Penny James to Board of Directors, ...
July 8, 2022
First Automated Benchtop Fire Monkey HMW-DNA Extraction Installed at Quadram Institute for Pathogen Sequencing and AMR Monitoring LONDON, July 8, 2022 /PRNewswire/ -- UK genomics company
July 8, 2022
/PRNewswire/ -- UK genomics company, RevoluGen Ltd. (RevoluGen or the Company), is pleased to announce that it has been selected as the winner of the 2022...
April 9, 2021
EMA CONTRADICTS HIS VACCINE’S EXPERT: RARE THROMBOSIS! BUSINESS MUST CONTINUE: WOMEN CAN EVEN DIED! The “benefits” of the AstraZeneca vaccine “outweigh the risks”. The EMA reiterates this in a note at the end of its evaluation. “Rare events” of cerebral thrombosis “are very rare side effects” of the AstraZeneca vaccine. This was reported by the EMA in a note. “EMA reminds healthcare professionals and people receiving the vaccine to remain aware of the possibility that very ...
April 7, 2021
“It is possible, for greater precaution, that the European Medicines Agency Ema indicates that for a certain category it is better not to use the AstraZeneca anti-Covid vaccine”. The Italian Undersecretary of Health Pierpaolo Sileri said on Radio 24, however, specifying that “this also happened for many other drugs” and that in the case of AstraZeneca the vaccine was used “in an extremely high number of subjects, while thrombotic events few reported are very few “. The UK drug agenc...